All nine practice areas sit at the intersection of validated production systems and GxP compliance in pharmaceutical, biotech, medical device, and CDMO manufacturing. Each requires regulatory depth, platform-specific experience, and the judgment that comes from working inside FDA-scrutinized operations.
End-to-end validation lifecycle ownership for SAP, Oracle, and related enterprise platforms in pharmaceutical, biotech, and medical device manufacturing. These professionals own IQ/OQ/PQ documentation, change control coordination, and inspection readiness for production-critical systems. They carry responsibility for maintaining compliant validation state through upgrades, patches, and configuration changes under active GxP operations.
Computer System Validation and Computer Software Assurance expertise across GAMP 5, 21 CFR Part 11, and EU Annex 11. Practitioners who can apply both legacy CSV protocols and the FDA's 2022 CSA guidance based on system risk classification, not just one approach across all systems. Pharmaceutical, biotech, and medical device manufacturing environments differ significantly in how they operationalize these frameworks, and experience in one does not automatically transfer to another.
QMS design, maintenance, and improvement in GxP-regulated pharmaceutical and biotech manufacturing where quality systems are integrated with validated ERP infrastructure. CAPA management, deviation handling, document control, and quality event workflows that function correctly under FDA inspection, not only in routine operations. Professionals with direct experience maintaining compliant QMS function during audits, warning letter responses, or consent decree oversight carry different value than those who have not.
Professionals who manage compliant change workflows, remediation initiatives, and deviation resolution under FDA regulatory scrutiny. Frequently engaged during FDA Form 483 observation responses, warning letter remediation, pre-inspection cleanup efforts, and consent decree support at pharmaceutical and biotech manufacturing sites.
Functional ownership of SAP QM, Oracle Quality, and related modules within validated, inspection-ready pharmaceutical and biotech manufacturing environments. These professionals bridge IT and quality operations, ensuring module configuration supports compliant manufacturing workflows, audit trails, and GxP documentation requirements.
Program-level oversight for ERP implementations, validation remediation programs, and system upgrade efforts in pharmaceutical, biotech, and CDMO manufacturing. These PMs understand validation lifecycle dependencies, cross-functional coordination between QA, IT, and manufacturing operations, and the regulatory consequences of schedule slippage when an FDA inspection date or remediation commitment is fixed. Technical project management without GxP context is not a substitute.
Deep expertise in SAP S/4HANA, SAP ECC, and SAP QM validation including IQ/OQ/PQ documentation and change-controlled operations in life sciences manufacturing. Specialists who have worked through SAP upgrades, GxP module configuration, and GRC/audit trail requirements in pharmaceutical and biotech environments under active regulatory scrutiny.
Validated integration and lifecycle management for manufacturing execution and laboratory information management systems in life sciences manufacturing. Experience with Werum PAS-X, DeltaV, LABVANTAGE, and similar platforms in pharmaceutical production environments and GLP laboratory settings supporting manufacturing quality operations.
Electronic records, electronic signatures, and audit trail compliance within validated enterprise technology ecosystems in pharmaceutical and biotech manufacturing. Practitioners who assess and remediate electronic records systems, ensure audit trail integrity, and support 21 CFR Part 11 and EU Annex 11 gap assessments in life sciences manufacturing environments.
Tell us about the role, its regulatory context, and your validated manufacturing environment. We will scope the search accordingly.